OCT 29, 2026 · PHASE 2 TRIAL
Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy
ClinicalTrials.gov
Registry record from ClinicalTrials.gov (NCT06680596). This is a study registration, not published results. Lead sponsor: UNICANCER. Recruitment status: RECRUITING. Phase: PHASE2.